IOCN 'Ask a Question' Webinar Series

This is a monthly free interactive webinar with cases and questions answered by a panel of experts. Join us to find out the answers to the questions you have on a different topic each month!

The'Ask a Question' webinar series is kindly sponsored by Merck Serono*

*Merck Serono have had no involvement in the production of content or agenda for this webinar series.​

IOCN 'New & Novel' Webinar Series

The field of immunotherapy for solid cancers is rapidly expanding beyond immune checkpoint inhibitors, bringing new challenges and toxicities for healthcare professionals to navigate. To address these issues, the IOCN is hosting a 'New and Novel' webinar series. This series will consist of four webinars focused on cutting-edge immunotherapeutics and their associated side effects, including CRS, HLH, and ICANS. Each webinar will be led by experts in the field, with ample opportunity for attendees to ask questions.Join us for this informative series to deepen your understanding of novel immunotherapeutics and their side effects.

This webinar series is kindly sponsored by Amgen, who have had no involvement in the production of the agenda for this webinar.

If you are interested in this event we would be very grateful if you could please complete the below form. If you have any questions or queries please email enquiries@ioclinicanetwork.co.uk.

• IOCN, Advancing the management of immunotherapy toxicities through case conundrums - Friday 21st March 2025, Novotel Reading Centre, 25B Friar Street, Reading, RG1 1DP.
  
  

  This event focuses on improving strategies for identifying and managing the adverse events associated with immunotherapy treatments. Through the presentation of interesting and complex clinical cases, experts will discuss innovative approaches, share best practices, and foster collaboration among healthcare professionals. The goal is to enhance patient care by addressing the challenges posed by immunotherapy side effects, ultimately leading to better treatment outcomes. This event is ideal for Doctors (including resident doctors, SpRs and Consultants), Nurses, AHP’s and Pharmacists. 

         Find out more information and book here.

Merck Sharp & Dohme (UK) Limited (MSD) and Bristol-Myers Squibb Pharmaceuticals Ltd (BMS) have kindly sponsored this event via the purchase of an exhibition stand space, and have no influence on the agenda or content of the day.

• Manchester Immuno-Oncology Network (MION), Emerging Approaches in Immuno-Oncology - Part 2 - Tuesday 25th March 2025, Oglesby Building (MCRC), Lecture Theatre & Foyer. 15:00 - 18:00
  
  View the agenda here.

• University of Birmingham -Understanding immune checkpoint blockade therapy: a pillar of modern cancer treatment
  
  An online 8 week course designed to benefit healthcare professionals, individuals working in industry, oncologists and cancer specialists, non-cancer specialists such as geneticists and basic immunologists, as well as patient groups and students (MSc, medical and undergraduates) with a background in science.
  Find out more information on the University of Birmingham website here.  

IOCN Service Showcase

Coming Soon!

The IOCN will be launching the Service Showcase webinar series in 2025!

Each webinar we will invite healthcare professionals from different trusts to discuss how they have developed an immunotherapy toxicity service, including the logistics, practicalities and governance of setting up a service. We are aware that immunotherapy toxicity services vary greatly throughout the UK and no one size fits all. The aim of this showcase is therefore to highlight how different services have been set up and run.